Sodium phenobarbital-enhanced mutation frequency in the liver DNA of lacZ transgenic mice treated with diethylnitrosamine

Mutagenesis

Volumn 12, Issue 3, 1997, Pages 179-184

  Okada, Naoko ^a   Honda, Ayako ^a   Kawabata, Masayoshi ^a   Yajima, Nobuhiro ^a  

^a SNOW BRAND MILK PRODUCTS CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; CELL DNA; DIETHYLNITROSAMINE; PHENOBARBITAL; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; DIET; LIVER; MALE; MOUSE; MUTATION RATE; NONHUMAN; PRIORITY JOURNAL; SAMPLING; TRANSGENE;

ANIMALS; BODY WEIGHT; CARCINOGENS; COCARCINOGENESIS; DIETHYLNITROSAMINE; DNA; DRUG SYNERGISM; LAC OPERON; LIVER; MALE; MICE; MICE, TRANSGENIC; MUTAGENS; MUTATION; ORGAN SIZE; PHENOBARBITAL;

EID: 0030946794     PISSN: 02678357     EISSN: None     Source Type: Journal    
DOI: 10.1093/mutage/12.3.179     Document Type: Article

References (23)

1. Ashby, J. and Leigibel, U. (1992) Transgenic mouse mutation assay: potential for confusion of genotoxic and non-genotoxic carcinogenesis: a proposed solution. Environ. Mol. Mutagen., 20, 145-147.
2. Ashby, J. and Tinwell, H. (1994) Use of transgenic mouse lacI/Z mutation assays in genetic toxicology. Mutagenesis, 9, 179-181.
3. Ashby, J. (1995) Transgenic germ cell mutation assay: a small collaborative study. Environ. Mol. Mutagen., 25, 1-3.
4. Brault, D., Bouilly, C., Renault, D. and Thybaud, V. (1996) Tissue-specific induction of mutations by acute oral administration of N-methyl-N′-nitro-N-nitrosoauanidine and β-propiolactone to the Muta™Mouse: preliminary data on stomach, liver and bone marrow. Mutat. Res., 360, 83-87.
5. Brooks, T.M, and Dean, S.W. (1996) Detection of gene mutation in skin, stomach and liver of Muta™Mouse following oral or topical treatment with N-methyl-N′-nitro-N-mtrosoguanidine or 1-chloromethylpyrene: some preliminary observations. Mutagenesis, 11, 529-532.
6. Collaborative Study Group for the Transgenic Mouse Mutation Assay Mammalian Mutagenesis Study Group of the Environmental Mutagen Society of Japan (1996) Organ variation in the mutagenicity of ethylnitrosourea in Muta™Mouse: results of the collaborative study on the transgenic mutation assay by JEMS/MMS. Environ. Mol. Mutagen., 28, 363-375.
7. Dean, S.W. and Myhr, B. (1994) Measurement of gene mutations in vivo using Muta™Mouse and positive selection for lacZ-phage. Mutagenesis, 9, 183-185.
8. Goldsworthy, T.L., Recio, L., Brown, K., Donehower, L.A., Mirsalis, J.C., Tennant, R.W. and Purchase, I.F.H. (1994) Symposium overview: transgenic animals in toxicology. Fund. Appl. Toxicol., 22, 8-19.
9. Gossen, J.A., De Leeuw, W.J.F., Tan, C.H.T., Zwarthoff, E.C., Berends, F., Lohman, P.H., Knook, D.L. and Vijg, J. (1989) Efficient rescue of integrated shuttle vectors from transgenic mice: a model for studying mutations in vivo. Proc. Natl. Acad. Sci. USA, 86, 7971-7975.
10. -. Nucleic Acids Res., 20, 3254.
11. - phage using a galactose-sensitive E.coli host. BioTechniques, 14, 326-330.
12. Gunz, D., Shephard, S.E. and Lutz, W.K. (1993) Can nongenotoxic carcinogens be detected with the lad transgenic mouse mutation assay? Environ. Mol. Mutagen., 21, 209-211.
13. Kohler, S.W., Provost, G.S., Kretz, P.L., Fieck, A., Sorge, J.A. and Short, J.M. (1990) The use of transgenic mice for short-term, in vivo mutagenicity testing. GATA, 7, 212-218.
14. Kohler, S.W., Provost, G.S., Fieck, A., Kretz, P.L., Bullock, W.O., Sorge, J.A., Putman, D.L. and Short, J.M. (1991) Spectora of spontaneous and mutagen-induced mutations in the lacI gene in transgenic mice. Proc. Natl. Acad. Sci. USA, 88, 7958-7962.
15. Lefevre, P.A., Tinwell, H., Galloway, S.M., Hill, R., Mackay, J.M., Elcombe, C.R., Foster, J., Randall, V., Callander, R.D. and Ashby, J. (1994) Evaluation of the genetic toxicity of the peroxisome proliferator and carcinogen methyl clofenapate, including assays using Muta™Mouse and Big Blue™ transgenic mice. Hum. Exp. Toxicol., 13, 764-775.
16. Mirsalis, J.C. (1995) Transgenic models for detection of mutations in tumors and normal tissues of rodents. Toxicol. Lett., 82/83, 131-134.
17. Mirsalis, J.C., Monforte, J.A. and Winegar, R.A. (1994) Transgenic animal models for measuring mutations in vivo. Clin. Rev. Toxicol., 24, 255-280.
18. Ponomarkov, V. and Tomatis, L. (1976) The effect of long-term administration of phenbarbitone in CF-1 mice. Cancer Lett., 1, 165-172.
19. Schulte-Herman, R., Bursch, W., Grasl-Kraupp, B., Müllauer, L. and Ruttkay-Nedecky. B. (1995) Apoptosis and multistage carcinogenesis in rat liver. Mutat. Res., 333, 81-87.
20. Schwarz, M., Buchmann, A., Stinchcombe, S., Luebeck, G., Moolgavkar, S. and Bock, K.W. (1995) Role of receptors in human and rodent hepatocarcinogenesis. Mutat. Res., 333, 69-79.
21. Suzuki, T., Hayashi, M., Myhr, B. and Sofuni, T. (1995) Diethylnitrosamine is mutagenic in liver but not in bone marrow of lacZ transgenic mice (Muta™Mouse). MMS Comm., 3, 33-39.
22. Suzuki, T., Hayashi, M., Ochiai, M., Wakabayashi, K., Ushijima, T., Sugimura, T., Nagao, M. and Sofuni, T. (1996) Organ variation in the mutagenicity of MeIQ in Big Blue™ lacI transgenic mice. Mutat. Res., 369, 45-49.
23. Vogelstein, B., Fearon, E.R., Hamilton, S.R., Kern, S.E., Preisinger, A.C., Leppert, M., Nakamura, Y., White, R., Smits, A.M. and Bos, J.L. (1988) Genetic alterations during colorectal-tumor development. N. Engl. J. Med., 319, 525-532.